×
ADVERTISEMENT

clear cell renal cell carcinoma

Survival Benefit Seen With Adjuvant Therapy in Patients With ccRCC

Adjuvant pembrolizumab (Keytruda, Merck) significantly improved overall survival in patients with clear cell renal ...

FEBRUARY 15, 2024

Load more